Beyfortus is used for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants born during or entering their first RSV season.
Retatrutide, an investigational molecule being studied for the treatment of obesity, met the primary endpoint for the efficacy estimand in participants.